Atossa Therapeutics, Inc.

ATOS ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
8-K Oct 9, 2026 8-K
8-K Sep 29, 2026 8-K
8-K Sep 18, 2026 8-K
8-K Aug 7, 2026 8-K
10-Q Aug 7, 2026 10-Q
424B5 Jun 12, 2026 424B5
8-K Jun 11, 2026 8-K
4 May 14, 2026 4
4 May 14, 2026 4
4 May 14, 2026 4
4 May 14, 2026 4
4 May 14, 2026 4
4 May 14, 2026 4
8-K May 8, 2026 8-K
10-Q May 8, 2026 10-Q
8-K May 8, 2026 8-K
8-K Apr 16, 2026 8-K
4 Mar 31, 2026 4
4 Mar 30, 2026 4
ARS Mar 30, 2026 ARS
DEF 14A Mar 30, 2026 DEF 14A
10-K Mar 25, 2026 10-K
8-K Mar 25, 2026 8-K
PRE 14A Mar 20, 2026 PRE 14A
8-K Feb 20, 2026 8-K
← Newer Page 1 of 26 · 641 filings Older →